International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

BACKGROUND: Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting) is an o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thromb J
Autori principali: Beyer-Westendorf, Jan, Camm, A. John, Fox, Keith A. A., Le Heuzey, Jean-Yves, Haas, Sylvia, Turpie, Alexander G. G., Virdone, Saverio, Kakkar, Ajay K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482585/
https://ncbi.nlm.nih.gov/pubmed/31169831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-019-0195-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi